NORVEX

Active Risk: not assessed

Private limited companyfounded 2026active for less than a yearMeulesteedsesteenweg 452, 9000 Gent, BelgiumKBO/BCE: BE 1038.915.134

Risk analysisFollow Report Compare

NORVEXActive

Risk analysis Report Compare

Acts, filings and financial milestones

All 3Gazette 3

2026

21-09

Gazette deed Transfer of 100 shares

Resignation: Sever Cebrail (director) · Appointment: Putnoki Ivan (director) · Director discharge7 points ▸

General meeting, 13-06-2026
Share transfer, Sever Cebrail → Putnoki Ivan
Director resignation, Sever Cebrail (director)
Director discharge, Sever Cebrail (director)
Director appointment, Putnoki Ivan (director)
Director in office, Sever Cebrail (director)
Director in office, Putnoki Ivan (director)

Open the act in the Belgian Official Gazette

21-09

Gazette deed Registered office moved from Willebroek to Gent

2 points ▸

General meeting, 14-06-2026
Registered-office move, Meulesteedsesteenweg 452, 9000 Gent

Open the act in the Belgian Official Gazette

15-06

Gazette deed Incorporation

Starting capital €500 · Appointment: SEVER Cebrail (director) · Founder5 points ▸

Incorporation, “NORVEX” (deed in Dutch)
Founder, SEVER Cebrail
Founding capital, €500
Board rule, 1
Director appointment, SEVER Cebrail (director)

Open the act in the Belgian Official Gazette

Gazette deed

Sources:Publications in the Belgian Official Gazette Filings with the National Bank

History

NORVEX was incorporated on 11 June 2026 as a private limited company by one natural person, with a starting capital of €500.¹² The registered office was moved to Gent in 2026.³ The board currently has 2 members.⁴